Benzinga - May 19, 2021, 5:03AM
Benzinga - May 6, 2021, 4:59PM
load more
Sector: Health Care.Industry: Biotechnology
Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VOR33.

Earnings

see more
Q2 2021Est.ActualSurprise
EPS
(EXPECTED)2021-09-08
REV
Q1 2021Est.ActualSurprise
EPS-0.670
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
VORVor Biopharma-3.42%

Vor Biopharma Frequently Asked Questions

Q

How do I buy Vor Biopharma (VOR) stock?

A

You can purchase shares of Vor Biopharma (NASDAQ: VOR) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Vor Biopharma's (VOR) competitors?

Q

What is the target price for Vor Biopharma (VOR) stock?

A

The latest price target for Vor Biopharma (NASDAQ: VOR) was reported by B. Riley Securities on March 25, 2021. The analyst firm set a price target for 60.00 expecting VOR to rise to within 12 months (a possible 205.89% upside). 5 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Vor Biopharma (VOR)?

A

The stock price for Vor Biopharma (NASDAQ: VOR) is $19.615 last updated Today at 5:14:52 PM.

Q

Does Vor Biopharma (VOR) pay a dividend?

A

There are no upcoming dividends for Vor Biopharma.

Q

When is Vor Biopharma (NASDAQ:VOR) reporting earnings?

A
Vor Biopharma’s Q2 earnings are confirmed for after-market on September 8, 2021.
Q

Is Vor Biopharma (VOR) going to split?

A

There is no upcoming split for Vor Biopharma.

Q

What sector and industry does Vor Biopharma (VOR) operate in?

A

Vor Biopharma is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.